A recently released collaborative report by two advocate organizations revealed that Big Pharma’s aggressive and often unlawful efforts to prevent competition and keep drug prices elevated have cost American patients, insurers and federal health programs more than $40 billion in 2019 alone. The report, released on May 16 by the American Economic Liberties Project (AELP) and the […]

www.newstarget.com